Synthetic carbohydrate-based antitumor vaccines: challenges and opportunities (Q36284550)

13 August 2017

1 reference

title

Synthetic carbohydrate-based antitumor vaccines: challenges and opportunities (English)

1 reference

13 August 2017

0 references

Ouathek Ouerfelli

1

1 reference

13 August 2017

J David Warren

series ordinal

2

1 reference

13 August 2017

Rebecca M Wilson

series ordinal

3

1 reference

13 August 2017

Samuel J Danishefsky

series ordinal

4

1 reference

13 August 2017

publication date

1 October 2005

1 reference

Expert Review of Vaccines

13 August 2017

published in

1 reference

13 August 2017

volume

4

1 reference

13 August 2017

issue

5

1 reference

13 August 2017

page(s)

677-685

1 reference

Emerging strategies in tumor vaccines.

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.677

Immunity against cancer: lessons learned from melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.677

From the Laboratory to the Clinic: A Retrospective on Fully Synthetic Carbohydrate-Based Anticancer Vaccines Frequently used abbreviations are listed in the appendix

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.677

Carbohydrate antigens as targets for active specific immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.677

Tolerance and cancer: mechanisms of tumor evasion and strategies for breaking tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.677

Selection of tumor antigens as targets for immune attack using immunohistochemistry: I. Focus on gangliosides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.677

The major T cell epitope on type II collagen is glycosylated in normal cartilage but modified by arthritis in both rats and humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.677

Polysaccharide processing and presentation by the MHCII pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.677

Tumor-associated carbohydrate antigens: a possible avenue for cancer prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.677

Synthetic GPI as a candidate anti-toxic vaccine in a model of malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.677

Carbohydrate vaccines in cancer: immunogenicity of a fully synthetic globo H hexasaccharide conjugate in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.677

Immunization of metastatic breast cancer patients with a fully synthetic globo H conjugate: a phase I trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.677

Vaccination of patients with small-cell lung cancer with synthetic fucosyl GM-1 conjugated to keyhole limpet hemocyanin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.677

Comparison of antigen constructs and carrier molecules for augmenting the immunogenicity of the monosaccharide epithelial cancer antigen Tn.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.677

Fully synthetic carbohydrate-based vaccines in biochemically relapsed prostate cancer: clinical trial results with alpha-N-acetylgalactosamine-O-serine/threonine conjugate vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.677

Pursuit of optimal carbohydrate-based anticancer vaccines: preparation of a multiantigenic unimolecular glycopeptide containing the Tn, MBr1, and Lewis(y) antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.677

On the power of chemical synthesis: immunological evaluation of models for multiantigenic carbohydrate-based cancer vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.677

Prospects for total synthesis: a vision for a totally synthetic vaccine targeting epithelial tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.677

A preclinical study comparing approaches for augmenting the immunogenicity of a heptavalent KLH-conjugate vaccine against epithelial cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.4.5.677

21 January 2018

Identifiers

DOI

10.1586/14760584.4.5.677

1 reference

13 August 2017

1 reference